{"meta":{"query_hash":"f7ce5b11d599","filters":{"venue":"Australasian biotechnology"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/f7ce5b11d599","api":"https://metacan.xera.ac/api/v1/cohort?venue=Australasian+biotechnology"},"results":[{"id":"W2285934247","doi":"","title":"International Financing Options Rise for Australian Biotechs: Selling Product Royalty Streams to Secure Non-dilutive Capital","year":2010,"lang":"en","type":"article","venue":"Australasian biotechnology","topic":"Private Equity and Venture Capital","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Finance; Capital (architecture); Business; Project commissioning; Product (mathematics); Publishing; Space (punctuation); Political science; Geography","score_opus":0.011820938120615607,"score_gpt":0.24804761901705794,"score_spread":0.23622668089644233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2285934247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9251516,0.000014524992,0.0040533603,0.06489221,0.0032647315,0.0011027739,0.00012865353,0.0005672356,0.0008248963],"genre_scores_gemma":[0.98749715,0.0000107388705,0.008924484,0.0003031176,0.0022456057,0.00010374689,0.00016293315,0.000047257185,0.00070498424],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979678,0.0000044933486,0.0003826418,0.0007467731,0.00018551566,0.00071278005],"domain_scores_gemma":[0.9989989,0.000022008906,0.00022294918,0.00052225444,0.00018654755,0.000047352605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024041673,0.000352189,0.00030850724,0.0006684713,0.00031255645,0.0002339686,0.00089183234,0.00064567395,0.00019305582],"category_scores_gemma":[0.00028743432,0.00035970358,0.00016342154,0.000602946,0.00021083897,0.0006803747,0.00033348764,0.00091015076,0.00037747397],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020204658,0.0007976098,0.0065381173,0.00033455688,0.0003584131,0.00010097739,0.0005768501,0.00043540564,0.50069904,0.36502004,0.060354687,0.06458227],"study_design_scores_gemma":[0.0014129122,0.00014489124,0.009181678,0.00011606516,0.00014958516,0.00006546153,0.0012933292,0.0012731135,0.07506795,0.012477989,0.89768577,0.0011312302],"about_ca_topic_score_codex":0.00015470693,"about_ca_topic_score_gemma":0.0003164681,"teacher_disagreement_score":0.8373311,"about_ca_system_score_codex":0.00006639981,"about_ca_system_score_gemma":0.000039559578,"threshold_uncertainty_score":0.9998855},"labels":[],"label_agreement":null},{"id":"W2756701234","doi":"","title":"Nexvet Biopharma - Seizing the opportunity in animal health","year":2013,"lang":"en","type":"article","venue":"Australasian biotechnology","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Project commissioning; Business; Socioeconomics; CATS; Agricultural economics; Pet therapy; Publishing; Demography; Veterinary medicine; Advertising; Demographic economics; Geography; Medicine; Economics; Animal welfare; Political science; Law; Biology; Sociology; Ecology; Internal medicine; Archaeology","score_opus":0.06665569293818359,"score_gpt":0.36596715087925885,"score_spread":0.2993114579410753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756701234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8338783,0.00021686926,0.000014088775,0.16407731,0.00006947201,0.00068513455,0.0000045483,0.0002061513,0.0008481365],"genre_scores_gemma":[0.95425266,0.000027852653,0.00018863569,0.045300215,0.000075360265,0.000068957015,0.000003385965,0.00002270088,0.000060207945],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982383,0.0000836212,0.0003476118,0.00036231504,0.00020548706,0.0007626524],"domain_scores_gemma":[0.99915975,0.000050160666,0.00008343154,0.0005730756,0.000043831984,0.00008976648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032425902,0.00018315534,0.00034185502,0.0004262775,0.00011387355,0.000030591254,0.00036994184,0.0004121458,0.00010687272],"category_scores_gemma":[0.00015835628,0.0001314643,0.000070722606,0.0008026238,0.00043975987,0.00009928012,0.00015326255,0.0011512596,0.00040801178],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000188454,0.0005854634,0.13258703,0.00023669614,0.00011787348,0.00063058984,0.0005787743,1.8590808e-7,0.65586734,0.008154449,0.021548405,0.17950475],"study_design_scores_gemma":[0.0034467317,0.0023544352,0.23088555,0.00014789766,0.00002981187,0.0012117121,0.0038225611,0.0004923862,0.33731696,0.0015226612,0.4183095,0.00045976837],"about_ca_topic_score_codex":0.0018309221,"about_ca_topic_score_gemma":0.000109629895,"teacher_disagreement_score":0.39676112,"about_ca_system_score_codex":0.00017074046,"about_ca_system_score_gemma":0.0004234976,"threshold_uncertainty_score":0.5360959},"labels":[],"label_agreement":null},{"id":"W2906279666","doi":"","title":"Medicinal marijuana: Commercialisation and innovation in a complex regulatory environment","year":2018,"lang":"en","type":"article","venue":"Australasian biotechnology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Legislation; Project commissioning; Competition (biology); Business; Face (sociological concept); State (computer science); Production (economics); Publishing; International trade; Industrial organization; Marketing; Economics; Political science; Law; Ecology","score_opus":0.016910660784537408,"score_gpt":0.29293394549381757,"score_spread":0.27602328470928017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906279666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895804,0.000107964646,0.0075092656,0.0023276627,0.000060859114,0.00011936682,0.0000039754486,0.000020551071,0.0002699354],"genre_scores_gemma":[0.9979219,0.00008610807,0.0015533167,0.00015123107,0.00011667009,0.000007471875,0.000069774454,0.000009515334,0.00008400346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935937,0.0000139955055,0.00018456184,0.0002247901,0.0000524298,0.0001648596],"domain_scores_gemma":[0.9997167,0.0000024121853,0.000040481667,0.00020679549,0.000012573257,0.000021040545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098796314,0.00009391279,0.00009455251,0.00020744947,0.0000343241,0.0000048591023,0.00007908451,0.00026838036,0.00003231011],"category_scores_gemma":[0.000022314292,0.00010170408,0.000010232995,0.00019082651,0.00028922415,0.0000021018247,0.00006925987,0.00009227384,0.000006287187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019836263,0.00002322699,0.009928638,0.000008587367,0.0000129104055,0.0000023802734,0.000048664133,0.0000113710685,0.94807994,0.003805205,0.0012993065,0.036759906],"study_design_scores_gemma":[0.0008625431,0.0006129581,0.41817275,0.000012080523,0.000012060485,0.000063465355,0.0002129604,0.00023145368,0.47398934,0.0006398898,0.10494847,0.00024204682],"about_ca_topic_score_codex":0.00001621647,"about_ca_topic_score_gemma":0.000053978016,"teacher_disagreement_score":0.47409064,"about_ca_system_score_codex":0.000015474283,"about_ca_system_score_gemma":0.000010272959,"threshold_uncertainty_score":0.4147372},"labels":[],"label_agreement":null}]}